Anthony Lucci

The University of Texas MD Anderson Cancer Center

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 23 papers. Top paper: “Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial”.

Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial

The Lancet Oncology(2022)10.1016/s1470-2045(22)00613-1

N/A

5.1DataRank · unranked

163 citations

Benjamin D. Smith, Savitri Krishnamurthy, Wei Yang, Vicente Valero, Yu Shen +31 more

Applications of Circulating Tumor Cells and Circulating Tumor DNA in Precision Oncology for Breast Cancers

International Journal of Molecular Sciences(2022)10.3390/ijms23147843

N/A

1.3DataRank · unranked

41 citations

Salyna Meas, Vanessa Nicole Sarli, Balraj Singh, Anthony Lucci, Sridevi Addanki

B cells and tertiary lymphoid structures promote immunotherapy response

Nature(2020)10.1038/s41586-019-1922-8

N/A

1.2DataRank · unranked

2719 citations

Sangeetha M. Reddy, Jianjun Gao, Shaojun Zhang, Rafet Başar, Rohit Thakur +55 more

Neoadjuvant relatlimab and nivolumab in resectable melanoma

Nature(2022)10.1038/s41586-022-05368-8

N/A

0.874DataRank · unranked

339 citations

Michael A. Postow, Elizabeth M. Burton, Michael T. Tetzlaff, Merrick I. Ross, Carlos A. Torres‐Cabala +35 more

Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

Nature(2022)10.1038/s41586-022-04833-8

N/A

0.731DataRank · unranked

130 citations

Michael G. White, Miles C. Andrews, Manoj Chelvanambi, Russell G. Witt, Joseph R. Daniele +60 more

Patient-Reported Outcomes of Omission of Breast Surgery Following Neoadjuvant Systemic Therapy

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.33933

N/A

0.652DataRank · unranked

12 citations

Heather Lin, Yu Shen, Emilia J. Diego, Savitri Krishnamurthy, Wei Yang +32 more

Eliminating Breast Surgery for Invasive Cancer with Exceptional Response to Neoadjuvant Systemic Therapy: Prospective Multicenter Clinical Trial Planned Initial Feasibility Endpoint

Journal of the American College of Surgeons(2023)10.1097/xcs.0000000000000670

N/A

0.373DataRank · unranked

11 citations

Vicente Valero, Wei Yang, Benjamin D. Smith, Savitri Krishnamurthy, Yu Shen +5 more

Lymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanoma

OncoImmunology(2025)10.1080/2162402x.2025.2546402

N/A

0.323DataRank · unranked

7 citations

Simin Kiany, Marie‐Andrée Forget, Roland L. Bassett, Michael A. Davies, Adi Diab +15 more

Self-Reported Management of Inflammatory Breast Cancer Among the American Society of Breast Surgeons Membership: Consensus and Opportunities

Annals of Surgical Oncology(2024)10.1245/s10434-024-15713-y

N/A

0.269DataRank · unranked

5 citations

Kerollos Nashat Wanis, Sydnee Brown, Anthony Lucci, Susie X. Sun, Taiwo Adesoye +6 more

Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma

Nature(2023)10.1038/s41586-023-05892-1

N/A

0.165DataRank · unranked

2 citations

Michael A. Postow, Elizabeth M. Burton, Michael T. Tetzlaff, Merrick I. Ross, Carlos A. Torres‐Cabala +35 more

Circulating tumour cell and cell-free DNA kinetics during radiotherapy in patients with intact head and neck squamous cell carcinoma

medRxiv(2020)10.1101/2020.10.13.20211516

N/A

0.104DataRank · unranked

1 citations

Carolyn Hall, Salyna Meas, Vanessa N. Sarli, Houda Bahig, Carlos Cárdenas +19 more

Impact of Postpartum Diagnosis on Survival of Women with Inflammatory Breast Cancer

Cancer Epidemiology Biomarkers & Prevention(2025)10.1158/1055-9965.epi-25-0829

N/A

0DataRank · unranked

0 citations

Rebecca S. Tidwell, Megumi Kai, Anthony Lucci, Wendy A. Woodward, Helen M. Johnson +20 more

Primary tumor surgery in patients with de novo stage IV breast cancer: Is there an optimal subgroup for locoregional therapy?

The American Journal of Surgery(2025)10.1016/j.amjsurg.2025.116700

N/A

0DataRank · unranked

0 citations

Zihan Yang, Zixi Yang, Salyna Meas, Abdulkader Almosa, Negar Koupaei +4 more

Androgen receptor activity promotes resistance to BRAF-targeted melanoma therapy

Research Square(2020)10.21203/rs.3.rs-58480/v1

N/A

0DataRank · unranked

0 citations

Christopher P. Vellano, Michael White, Miles C. Andrews, Joseph R. Daniele, Mark Titus +41 more

Inhibition of resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine

Oncotarget(2021)10.18632/oncotarget.27922

N/A

0DataRank · unranked

18 citations

Vanessa N. Sarli, Anthony Lucci, Balraj Singh

Immediate Breast Reconstruction in Inflammatory Breast Cancer: Are We There Yet?

Annals of Surgical Oncology(2022)10.1245/s10434-022-11788-7

N/A

0DataRank · unranked

5 citations

Susie X. Sun, Mark V. Schaverien, Wendy A. Woodward, Anthony Lucci, Taiwo Adesoye

Sensitization of resistant cells with a BET bromodomain inhibitor in a cell culture model of deep intrinsic resistance in breast cancer

Research Square(2022)10.21203/rs.3.rs-1832724/v1

N/A

0DataRank · unranked

0 citations

Vanessa N. Sarli, Ryan D. Milligan, Hannah E. Kinne, Anna Shamsnia, Laura J. Washburn +2 more

Presence of Circulating Tumor Cells Predates Imaging Detection of Relapse in Patients with Stage III Melanoma

Cancers(2023)10.3390/cancers15143630

N/A

0DataRank · unranked

7 citations

Sridevi Addanki, Yi‐Ju Chiang, Salyna Meas, Vanessa N. Sarli, Joshua Upshaw +6 more

Sensitization of Resistant Cells with a BET Bromodomain Inhibitor in a Cell Culture Model of Deep Intrinsic Resistance in Breast Cancer

Cancers(2023)10.3390/cancers15072036

N/A

0DataRank · unranked

6 citations

Vanessa N. Sarli, Ryan D. Milligan, Hannah E. Kinne, Anna Shamsnia, Laura J. Washburn +3 more

Data from Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Reverses Mesenchymal to Epithelial Phenotype and Inhibits Metastasis in Inflammatory Breast Cancer

(2023)10.1158/1078-0432.c.6517681.v1

N/A

0DataRank · unranked

0 citations

Tiffany A. LaFortune, Savitri Krishnamurthy, Francisco J. Esteva, Massimo Cristofanilli, Ping Liu +6 more

Monitoring response to neoadjuvant chemotherapy in triple negative breast cancer using circulating tumor DNA

BMC Cancer(2024)10.1186/s12885-024-12689-6

N/A

0DataRank · unranked

26 citations

Sridevi Addanki, Dhruvajyoti Roy, Roland L. Bassett, Ekaterina Kalashnikova, Erik Spickard +16 more

Monitoring Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer Using Circulating Tumor DNA

Research Square(2024)10.21203/rs.3.rs-4104393/v1

N/A

0DataRank · unranked

0 citations

Sridevi Addanki, Dhruvajyoti Roy, Roland L. Bassett, Ekaterina Kalashnikova, Erik Spickard +16 more

Neoadjuvant HER2-targeted regimens with or without anthracyclines for HER2-positive inflammatory breast cancer: a multicenter retrospective study

Breast Cancer Research and Treatment(2025)10.1007/s10549-025-07795-3

N/A

0DataRank · unranked

0 citations

N Sridhar, Megumi Kai, Wenli Dong, Shen Yu, Savitri Krishnamurthy +14 more